ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,067.33
0.11%
US Tech 100
17,282.20
0.23%
Dow Jones
37,889.77
0.41%
Brent Oil
89.62
-0.28%
Bitcoin
62,959.17
-0.73%
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Marinus Pharmaceuticals Inc (MRNS) Quote

Marinus Pharmaceuticals Inc

Marinus Pharmaceuticals Inc (MRNS)

-3x Mrna
1.20
-0.10
( -7.69% )
Updated: 15:16:39
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
1.20
Bid
1.19
Ask
1.20
Volume
17,436,743
1.11 Day's Range 1.65
1.11 52 Week Range 11.26
Market Cap
64.478M
Previous Close
1.30
Open
1.32
Last Trade
100
@
1.2
Last Trade Time
15:16:39
Financial Volume
$ 22,171,767
VWAP
1.2716
Average Volume (3m)
1,054,817
Shares Outstanding
54,642,580
Dividend Yield
-
PE Ratio
-0.46
Earnings Per Share (EPS)
-2.59
Revenue
30.99M
Net Profit
-141.41M

About Marinus Pharmaceuticals Inc

Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychi... Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19 pediatric epilepsy. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.marinuspharma.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Marinus Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MRNS. The last closing price for Marinus Pharmaceuticals was $1.30. Over the last year, Marinus Pharmaceuticals shares have traded in a share price range of $ 1.11 to $ 11.26.

Marinus Pharmaceuticals currently has 54,642,580 shares outstanding. The market capitalization of Marinus Pharmaceuticals is $64.48 million. Marinus Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.46.

MRNS Latest News

More News

Marinus Pharmaceuticals Provides Update on the Phase 3 RAISE Trial and Reports Preliminary First Quarter 2024 Financial Results

Trial did not meet pre-defined stopping criteria at the interim analysis; Marinus has completed RAISE enrollment at approximately 100 patients with topline results expected summer 2024 Future...

April 15 2024
Business Wire

Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced the grant of inducement...

April 05 2024
Business Wire

Marinus Pharmaceuticals Comments on Patent Challenge by Ovid Therapeutics Inc. and Provides Update on Marinus’ Post Grant Review

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to developing and commercializing innovative therapeutics to treat seizure disorders, today affirmed its...

March 27 2024
Business Wire

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

March 05 2024
Edgar (US Regulatory)

Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Phase 3 RAISE trial interim analysis enrollment target achieved with Data Monitoring Committee (DMC) review scheduled and topline results expected in first half of Q2 2024 Phase 3 TrustTSC trial...

March 05 2024
Business Wire

Form 4 - Statement of changes in beneficial ownership of securities

February 22 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

February 21 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

February 21 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

February 21 2024
Edgar (US Regulatory)

Marinus Pharmaceuticals to Present at Upcoming Investor Conferences

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that management will...

February 21 2024
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-6.98-85.33007334968.188.451.1175629451.71797848CS
4-7.8-86.666666666799.51.1123693712.83471336CS
12-9.07-88.315481986410.2710.51.1110548174.60283766CS
26-5.75-82.73381294966.9511.261.117251335.80293947CS
52-6.29-83.97863818427.4911.261.117594067.25203677CS
156-13.16-91.64345403914.3619.831.114599517.71166006CS
260-2.97-71.22302158274.1720.040.779912384.64094838CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WISAWiSA Technologies Inc
$ 5.4495
(211.40%)
175.42M
JAGXJaguar Health Inc
$ 0.182
(53.20%)
515.19M
SXTCChina SXT Pharmaceuticals Inc
$ 1.6399
(40.16%)
32.9M
PALIPalisade Bio Inc
$ 5.8081
(39.62%)
21.81M
KAKineta Inc
$ 0.474
(39.41%)
4.73M
PACBPacific Biosciences of California Inc
$ 1.485
(-47.62%)
44.73M
PPBTPurple Biotech Ltd
$ 0.3834
(-34.28%)
910.31k
RVYLRYVYL Inc
$ 1.4499
(-29.65%)
819.33k
KAVLKaival Brands Innovations Group Inc
$ 4.485
(-28.81%)
1.57M
SYTASiyata Mobile Inc
$ 2.39
(-28.01%)
53.26k
JAGXJaguar Health Inc
$ 0.182
(53.20%)
515.19M
WISAWiSA Technologies Inc
$ 5.47
(212.57%)
175.42M
SQQQProShares UltraPro Short QQQ
$ 11.345
(-0.83%)
149.05M
TSLATesla Inc
$ 156.58
(-3.03%)
69.21M
NKLANikola Corporation
$ 0.6681
(2.22%)
67.09M

MRNS Discussion

View Posts
Money hunt Money hunt 6 hours ago
1.27 Wall gong to get busted down Watch out shorties,
👍️0
Money hunt Money hunt 6 hours ago
MRNS Has got bulls with balls dude
👍️0
Money hunt Money hunt 6 hours ago
Watch out shorties We the Next PALI So you can all burn in hell where you belong
👍️0
ErnieBilco ErnieBilco 1 day ago
MRSN under $2
👍️0
Awl416 Awl416 1 day ago
Marinus Pharmaceuticals Provides Update on the Phase 3 RAISE Trial and Reports Preliminary First Quarter 2024 Financial Results
👍️0
Monksdream Monksdream 2 weeks ago
MRNS under $10
👍️0
oldstocks oldstocks 2 months ago
Drug Companies making Epilepsy medication
MRNS $10.08
CERE $43.16
STOK $4.98
UCBJF $102.00
SNY $45.63
PFE $27.00
OTSUK $18.36
RespireRx Pharmaceuticals Ticker: RSPI
Is working on Revolutionary New Hope:
KRM-II-81 Drug-Resistant Epilepsy Patients

Don't take my word for it, look at the links that talk about it.

Link found on National Library of Medicine
The imidazodiazepine, KRM-II-81: An example of a newly emerging generation of GABAkines for neurological and psychiatric disorders

https://pubmed.ncbi.nlm.nih.gov/35041859/

https://www.neurexplain.com/2024/01/17/revolutionary-krm-ii-81-a-new-hope-for-drug-resistant-epilepsy-patients/

National Institutes of Health
A clinical case of a 19-year-old male patient with pharmacoresistant seizures occurring following parieto-occipital tumor-resection at age 6 ...
KRM–II–81 suppresses epileptifom activity across the neural network of cortical tissue from a patient with pharmacoresistant epilepsy
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10784158/
👍️0
matt51 matt51 11 months ago
Has Marinus enrolled the eighty-second patient for the phase 3 RSE trial?
👍️0
Cosa Cosa 12 months ago
Did you add more here? This recovered well from the bottom. I was putting all into ARDX and AUPH, didn't add any here.
👍️0
Cosa Cosa 1 year ago
Thanks, I will look.
👍️0
Ganz Ganz 1 year ago
Ha, our time is coming for MRNS Cosa, also check out MIRM
👍️0
Cosa Cosa 2 years ago
Good thing that's all you had lol! This is definitely not volatile enough to trade. And a good investment?...Time will tell.
👍️0
missile_systems missile_systems 2 years ago
Yeah Buddy…. Hoping for good news.
Just stumbled upon this on Friday afternoon.
Only had enough powder to grab a hundred shares.
Please don’t laugh too hard….lol.

Anyway, it’s weird that there haven’t been any posts on this board since before last Christmas!

Peace
mis
👍️0
Cosa Cosa 2 years ago
let's see what happens Monday...
👍️0
Cosa Cosa 2 years ago
Everything I have is Red, not a single green. lol!
👍️0
flsh56 flsh56 2 years ago
... don't look now, it's been six months since this happened, but mrns just decently broke through their 50dma
👍️0
Ganz Ganz 3 years ago
Cosa, you there ?
👍️0
Ganz Ganz 3 years ago
Cosa, good to see you on this board, MRNS - like AUPH - is primed to pop.
👍️0
whytestocks whytestocks 4 years ago
JUST IN: $MRNS 3 Biotech Stocks That Surged Last Week

Dozens of healthcare stocks grew by double-digit percentages last week, and shares of these three drugmakers rose further than nearly all of their peers. Clinical trial results, coronavirus vaccine progress, and a buyout were the major factors that turned these biotech stocks into big gainers la...

Read the whole news MRNS - 3 Biotech Stocks That Surged Last Week
👍️0
ClayTrader ClayTrader 4 years ago
* * $MRNS Video Chart 09-15-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
Cosa Cosa 4 years ago
Woohoo! Huge upswing
👍️0
whytestocks whytestocks 4 years ago
NEWS: $MRNS Top Penny Stocks To Buy, Sell Or Hold? Analysts Weigh In On These 4

4 Penny Stocks To Buy Right Now According To Analysts Whether you buy penny stocks because of analysts or simply use ratings in your overall strategy, it helps to get a full lay of the land. What I mean by this is that most retail traders will look at a few facets of certain companies. They...

Find out more MRNS - Top Penny Stocks To Buy, Sell Or Hold? Analysts Weigh In On These 4
👍️0
whytestocks whytestocks 4 years ago
Breaking News: $MRNS Nasdaq Rises Despite Nikola Hit; Marinus Soars

Many investors have been worried about the Nasdaq Composite (NASDAQINDEX: ^IXIC) lately. The index has taken a leadership role during 2020's huge rebound from the coronavirus bear market, but its steep decline in early September made some believe that the best of times for the Nasdaq were no...

Got this from MRNS - Nasdaq Rises Despite Nikola Hit; Marinus Soars
👍️0
UFO UFO 4 years ago
Just announced phase #3 results rocked. Stock is on the way to $10+.

UFO
👍️0
MKthe great MKthe great 4 years ago
??????
👍️0
UFO UFO 4 years ago
Go Marinus!

UFO
👍️0
whytestocks whytestocks 4 years ago
News: $MRNS Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial Results

Clinical trials remain on track, with Refractory Status Epilepticus (SE) trial expected to begin enrollment shortly CDKL5 deficiency disorder (CDD) pivotal topline results on track for Q3; Conference call to be scheduled to discuss CDD data release and business update Organiz...

Find out more MRNS - Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial Results
👍️0
UFO UFO 4 years ago
On the move!

UFO
👍️0
ClayTrader ClayTrader 4 years ago
* * $MRNS Video Chart 05-29-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
UFO UFO 4 years ago
Go Marinus!

UFO
👍️0
agribusiness72 agribusiness72 4 years ago
minor pump from yahoo finance. will see how low it drops before buying in.
👍️0
UFO UFO 4 years ago
Looks like a move is on.

UFO
👍️0
ClayTrader ClayTrader 4 years ago
* * $MRNS Video Chart 03-16-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
ClayTrader ClayTrader 4 years ago
* * $MRNS Video Chart 02-20-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
ClayTrader ClayTrader 4 years ago
* * $MRNS Video Chart 02-18-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
nuclear profitz nuclear profitz 4 years ago
breaking out.
👍️0
Cosa Cosa 4 years ago
Good points. I'm sure they will find something it works on. The science behind it is still unknown. The good thing about ganaxolone is it has very little side effects. So if one of the phases does well it is a gold mine! I traded on the momentum and will get back in a little cheaper and a lot less shares so there is no stress lol.

I like Epidiolex seems to be gaining momentum since it's FDA approval last year. It targets the same symptoms of ganaxolone with very little side effects also.

Good luck to you!
👍️0
UFO UFO 4 years ago
All I've seen them have an issue with is one trial. Now they have a treasure chest full of money and some aggressive money manager backing. IMHO, this would be the WORST time to bail out on the company. Did you read the corporate outlook that was released today? They have about 4 trials in progress and the ability to fund them all. You think ganaxolone is going to fail on all of them? I like the odds here. At the least I think we'll see a rally into the Phase 3 results that we'll see later this year. Go Marinus!

UFO
👍️0
Cosa Cosa 4 years ago
The more I research this stock the more I do not like. Ganaxolone doesnt look like it is doing well in clinical trials.
👍️0
ClayTrader ClayTrader 4 years ago
* * $MRNS Video Chart 12-24-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
Cosa Cosa 4 years ago
Could see that big move up sometime next month

https://www.nasdaq.com/articles/implied-volatility-surging-for-marinus-pharmaceuticals-mrns-stock-options-2019-12-23
👍️0
UFO UFO 4 years ago
Agreed. I've never seen a stock rally like this as a "major" financing is going on! Somebody knows something...just saying...

UFO
👍️0
Cosa Cosa 4 years ago
Possible 10 bagger with a short squeeze.
👍️0
UFO UFO 4 years ago
Go Marinus!

UFO
👍️0
ClayTrader ClayTrader 4 years ago
* * $MRNS Video Chart 12-20-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
UFO UFO 4 years ago
If they get GREAT results from their phase 3, this is a $40 - $50 stock!

UFO
👍️0
Cosa Cosa 4 years ago
If they pass a phase 3 this is going to $10 - $16
👍️0
Cosa Cosa 4 years ago
I'm late to the party. Just got in, more room to grow
👍️0
UFO UFO 4 years ago
Gap higher! Where are all you Marinus holders? This baby is on the move!

UFO
👍️0
UFO UFO 4 years ago
Yesterday was a consolidation day for $MRNS after a breakout Wednesday on heavy volume. The stock looks to be up a few pennies in the pre-market. I'm looking for signs that this recent positive activity has legs. I like to add to winning positions, so I'll be watching carefully for how the stock reacts to the $2.00 level (if it gets there). Between 9/4 and 9/26 an earlier rally attempt was rejected there 4 times. A close above $2.00 would be a HUGE buy signal on Marinus!

UFO
👍️0

Your Recent History

NASDAQ
MRNS
Marinus Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved